George Yancopoulos, President and Chief Scientific: Regeneron Pharmaceuticals REGN Sell · Filed 23/03/27

Trade details

Type: Insider sale
Amount: $992,741.98
Shares · price: 1,237 sh · $802.54 a share
Held after: 198,891 sh
Stock: Regeneron Pharmaceuticals REGN
Person: George YancopoulosPresident and Chief Scientific
Trade date: 23/03/23
Filed: 23/03/27
Days to filing: 4 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

Regeneron Pharmaceuticals trades, last 26 weeks

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/02/21~23/04/22

George Yancopoulos's recent trades

George YancopoulosBd. Co-Chair, President & CSO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$9.2M
9,501 sh
$9.2M
Filed 24/05/17
Traded 24/05/16
George YancopoulosBd. Co-Chair, President & CSO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$9M
9,242 sh
$9M
Filed 24/05/17
Traded 24/05/16
George YancopoulosBd. Co-Chair, President & CSO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$7.4M
7,611 sh
$7.4M
Filed 24/05/17
Traded 24/05/16
George YancopoulosBd. Co-Chair, President & CSO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$4.8M
4,922 sh
$4.8M
Filed 24/05/17
Traded 24/05/16
George YancopoulosBd. Co-Chair, President & CSO
Sell10b5-1 planRegeneron Pharmaceuticals
Sell10b5-1 plan
Regeneron Pharmaceuticals
REGN
$4.8M
4,886 sh
$4.8M
Filed 24/05/17
Traded 24/05/16

George Yancopoulos, Chief Officer — sold $992.7K of Regeneron Pharmaceuticals REGN · 0.6% of holdings · 10b5-1 plan | Whalegun